In a recently published guidance, the ASN aims to help patients with kidney disease navigate the risks inherent to potassium ...

Dublin, March 19, 2021 (GLOBE NEWSWIRE) -- The "Hyperkalemia - Market Insight, Epidemiology and Market Forecast - 2030" drug pipelines has been added to ResearchAndMarkets.com's offering. This report ...

Although serum potassium monitoring is recommended to reduce the risk of hyperkalemia, only a small percentage of patients taking RAAS inhibitors are monitored. Hyperkalemia diagnosis is often missed ...

Share on Facebook. Opens in a new tab or window Share on Bluesky. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window As explained by ...

In a European study, approximately one-third of hospitalizations involving patients with recurrent hyperkalemia directly related to serum potassium elevation. Recurrent hyperkalemia is a major cause ...

Postoperative hyperkalemia is an important complication of adrenalectomy for aldosterone-producing adenoma. Recently, postoperative hyperkalemia has been found to have a relatively high incidence ...

senior man_TS_519664464 KDQOL and EuroQol-5D-3L responses show worse quality of life among kidney disease patients who develop hyperkalemia. WASHINGTON—Hyperkalemia reduces the quality of life of ...

An analysis of transgender teens prescribed spironolactone showed that only 2.2% developed hyperkalemia after initiating therapy, with all cases resolving upon repeat measurement irrespective of ...

Hyperkalemia is an abnormally high level of potassium in the blood. The normal level of serum potassium (potassium in the fluid portion of the blood) is 3.5 to 5.0 mmol/l. When serum potassium is ...

Patients taking renin-angiotensin-aldosterone system inhibitor (RAASi) medications for heart failure had significantly lower blood potassium levels when taking patiromer—a drug that helps to prevent ...

Credit: Getty Images. Trimethoprim-sulfamethoxazole is mostly excreted through the kidneys, and it can cause hyperkalemia by reducing potassium excretion. Antibiotic treatment with oral ...

LONDON--(BUSINESS WIRE)--Technavio analysts forecast the global hyperkalemia drugs market to grow at a CAGR of over 20% during the period 2019-2023, according to their latest market research report.